🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to demonstrate the safety and efficacy of a second t...
Status
Completed
Location
For information concerning this clinical site, please contact Nymox at 800-936-9669.
Start Date
2011-09
Trial ID
NCT01438775
Treatments Being Tested
This completed study evaluated the safety and efficacy of two dose levels o...
Status
Completed
Location
Nymox Investigational Site
Start Date
2007-05
Trial ID
NCT00759135
Treatments Being Tested
This study will evaluate the safety and efficacy of a 2.5 mg dose of NX-120...
Status
Completed
Location
For information concerning this clinical site, please contact Nymox at 800-936-9669.
Start Date
2009-05
Trial ID
NCT00945490
The purpose of the this international, multicenter, randomised, single-blin...
Status
Terminated
Location
Klinikum der Ludwig-Maximilians-universität München
Start Date
2013-09
Trial ID
NCT02003742
Treatments Being Tested
This study is designed to demonstrate the safety and efficacy of a second t...
Status
Completed
Location
For information concerning this clinical site, please contact Nymox at 800-936-9669.
Start Date
2013-04
Trial ID
NCT01846793
Treatments Being Tested
This study will evaluate the safety and efficacy of a 2.5 mg dose of NX-120...
Status
Completed
Location
For information concerning this clinical site, please contact Nymox at 800-936-9669
Start Date
2009-04
Trial ID
NCT00918983
This study is designed to evaluate the safety and efficacy of a single inje...
Status
Completed
Location
For information concerning this clinical site, please contact Nymox at 800-936-9669.
Start Date
2012-02-21
Trial ID
NCT01620515
Treatments Being Tested